AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Start an online business using social media effectively. Leverage these strategies to connect with your audience and grow your brand.
21,077 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Strategy unveiled a broad capital-management package to steady its Bitcoin-buying strategy, but analysts say the next...
A surprising line in a public financial disclosure turned into a teaching moment for everyday investors. Learn what t...
Tariff refunds total about $71 billion by June, yet inflationary pressure from the Iran conflict muffles the relief a...
Hedge funds are chasing a single megacap, creating crowded trades. Learn what crowdedness means, how to read the sign...
Greg Abel, two months into his role as Berkshire Hathaway CEO, commits to using his after-tax salary to buy Berkshire...
Ballard Power is at a pivotal moment as 2025 unfolds. This guide breaks down what to watch in the Q4 transcript, how ...
A new deduction for interest on auto loans for 2025 buyers could cut tax bills even for standard-deduction filers. Bu...
The Trump administration is weighing a measure to compensate TSA officers who have gone unpaid during a prolonged par...
A sudden price glitch on a popular trading app sent bitcoin price crashes near zero for a moment, leaving traders puz...
Bank of America lifts Micron Technology's price target to $950, arguing a larger AI data-center market drives sustain...
Nvidia's upcoming earnings could be the turning point for AI stocks. This article breaks down what to watch, possible...